Subscribe to Newsletter

Business Practice

Business & Regulation Business Practice

Drug Price Negotiations, Counteroffers, and Lawsuits

| Stephanie Vine | 4 min read

The US Inflation Reduction Act continues to generate controversy as drugmakers make counteroffers.

Business & Regulation Business Practice

Tips for Development Success in a Troubling Economic Environment

Ali Pashazadeh from Treehill Partners offers his advice for navigating the turbulent period and keeping on track for commercial success.

Business & Regulation Business Practice

Being Mindful of the World

| Stephanie Vine | 10 min read

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.

Business & Regulation Business Practice

Active Manufacturing Responsibility and the Other AMR

| Marijn Verhoef, Martijn van Gerven | 5 min read

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

Business & Regulation Standards & Regulation

The Underworld of Counterfeit Fentanyl

| Jamie Irvine | 6 min read

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

Business & Regulation Business Practice

Who’s the Best?

Voting is now open for the 2024 Company of the Year Awards – vote for the best big pharma, best CDMO, and more!

Manufacture Advanced Medicine

Leading with the Heart

| 6 min read

AskBio CEO Sheila Mikhail shares the story behind her success and her strength

Manufacture Technology and Equipment

MES: Just What the Doctor Ordered

| Nic Azad | 3 min read

How manufacturing execution systems can help with sustainability strategies

Manufacture Process Control

Advanced Manufacturing

| Rob Coker

Watch our roundtable discussion featuring experts from TrakCel, Ori Biotech, ScaleReady, and RoslinCT

Manufacture Contract Manufacturing Services

May the Outsource Be With You

| Nandu Deorkar, Greg Swan | 7 min read

Experts suggest that outsourcing CGT manufacturing capabilities to CDMOs brings additional benefits, although not without challenges


Latest White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register